Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Bausch and Lomb Inc | 60 |
| 2 | Koninklijke Philips NV | 47 |
| 3 | Allergan Inc | 33 |
| 4 | Insmed Inc | 30 |
| 5 | aTyr Pharma Inc | 20 |
| 6 | Bayer CropScience AG | 19 |
| 7 | US Department of Health and Human Services | 19 |
| 8 | Aradigm Corp | 18 |
| 9 | Santen Pharmaceutical Co Ltd | 18 |
| 10 | BASF SE | 16 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 715 |
| 2 | A61P | Therapeutic activity (drug indications) | 637 |
| 3 | C07D | Heterocyclic compounds | 142 |
| 4 | Y02A | Climate change adaptation | 136 |
| 5 | A61L | Sterilising / disinfecting materials | 102 |
| 6 | C12N | Microorganisms, enzymes | 98 |
| 7 | C07K | Peptides | 90 |
| 8 | A61F | 72 | |
| 9 | A01N | Preservation of bodies; biocides; pest repellents | 68 |
| 10 | C07C | Acyclic and carbocyclic compounds | 54 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| TWO-COMPONENT DIAZON TYPE MATERIAL | 1984 | Hoechst AG | 2 |
| Diamidine compounds as DNA minor groove binders | 2007 | University of North Carolina at Chapel Hill | 1 |
| BLACK OF SMOKE THAT HAS REACTED WITH DIAZON SALTS. | 2006 | Cabot Corp | 0 |
| PROCEDURE FOR THE PRODUCTION OF WATER SOLUTIONS OF DIAZON SALTS. | 2003 | Clariant Produkte Deutschland GmbH | 0 |
| DIAMIDINE COMPOUNDS AS DNA MINOR GROOVE BINDERS | 2002 | University of North Carolina at Chapel Hill | 0 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | E. Carboni | 3 | |
| 2 | J. Martínez‐Fernández | 3 | |
| 3 | Carleen Klumpp‐Thomas | National Institutes of Health | 2 |
| 4 | Chris M. Ireland | University of Utah | 1 |
| 5 | Doull Ja | 2 |
| 6 | Gerhard Raabe | RWTH Aachen University | 2 |
| 7 | Hans‐Joachim Gais | RWTH Aachen University | 2 |
| 8 | Jennifer M. Schomaker | University of Wisconsin–Madison | 2 |
| 9 | Joy Barnes Cross | The University of Texas Medical Branch at Galveston | 2 |
| 10 | Matthew D. Hall | National Institutes of Health | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Diastereomerically and Enantiomerically Pure 2,3-Disubstituted Pyrrolidines from 2,3-Aziridin-1-ols Using a Sulfoxonium Ylide: A One-Carbon Homologative Relay Ring Expansion | 2007 | 91 | Asymmetric Synthesis and Catalysis |
| Ligand-Controlled Synthesis of Azoles via Ir-Catalyzed Reactions of Sulfoxonium Ylides with 2-Amino Heterocycles | 2016 | 77 | Catalytic C–H Functionalization Methods |
| Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. | 1986 | 67 | Neutrophil, Myeloperoxidase and Oxidative Mechanisms |
| Total Synthesis of Azumamide A and Azumamide E, Evaluation as Histone Deacetylase Inhibitors, and Design of a More Potent Analogue | 2007 | 54 | Catalytic C–H Functionalization Methods |
| SULFOXONE (DIASONE®) SODIUM FOR DERMATITIS HERPETIFORMIS | 1951 | 38 | Celiac Disease Research and Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Diazon?
Which organizations hold the most patents related to Diazon?
How many patents and papers are in the database for Diazon, and what is the recent activity?
What are the primary patent classification codes associated with Diazon research?
What notable research topics are associated with papers on Diazon?